230 related articles for article (PubMed ID: 23394117)
21. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
22. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
López-Moreno JA; González-Cuevas G; Navarro M
Neurobiol Dis; 2007 Feb; 25(2):274-83. PubMed ID: 17067804
[TBL] [Abstract][Full Text] [Related]
23. Prenatal and postnatal exposure to bisphenol a induces anxiolytic behaviors and cognitive deficits in mice.
Tian YH; Baek JH; Lee SY; Jang CG
Synapse; 2010 Jun; 64(6):432-9. PubMed ID: 20169576
[TBL] [Abstract][Full Text] [Related]
24. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
Zhang RS; He Z; Jin WD; Wang R
Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221
[TBL] [Abstract][Full Text] [Related]
25. The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala.
Dono LM; Currie PJ
Neuropharmacology; 2012 Jan; 62(1):192-9. PubMed ID: 21736884
[TBL] [Abstract][Full Text] [Related]
26. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Balerio GN; Aso E; Maldonado R
Psychopharmacology (Berl); 2006 Mar; 184(3-4):504-13. PubMed ID: 16416159
[TBL] [Abstract][Full Text] [Related]
27. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice.
Da S; Takahashi RN
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):321-5. PubMed ID: 11817511
[TBL] [Abstract][Full Text] [Related]
28. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
Haller J; Varga B; Ledent C; Freund TF
Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
[TBL] [Abstract][Full Text] [Related]
29. Long-term CB₁ receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids.
Tambaro S; Tomasi ML; Bortolato M
Neuropharmacology; 2013 Jul; 70():268-77. PubMed ID: 23462228
[TBL] [Abstract][Full Text] [Related]
30. Prenatal nicotine exposure in mice induces sex-dependent anxiety-like behavior, cognitive deficits, hyperactivity, and changes in the expression of glutamate receptor associated-genes in the prefrontal cortex.
Polli FS; Scharff MB; Ipsen TH; Aznar S; Kohlmeier KA; Andreasen JT
Pharmacol Biochem Behav; 2020 Aug; 195():172951. PubMed ID: 32439454
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
Patel S; Hillard CJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
[TBL] [Abstract][Full Text] [Related]
32. 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze.
Rodgers RJ; Haller J; Halasz J; Mikics E
Eur J Neurosci; 2003 Mar; 17(6):1279-86. PubMed ID: 12670316
[TBL] [Abstract][Full Text] [Related]
33. Nicotine ameliorates impairment of working memory in methamphetamine-treated rats.
Mizoguchi H; Ibi D; Takase F; Nagai T; Kamei H; Toth E; Sato J; Takuma K; Yamada K
Behav Brain Res; 2011 Jun; 220(1):159-63. PubMed ID: 21277906
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological effects of cannabinoids on the reference and working memory functions in mice.
Avdesh A; Hoe Y; Martins RN; Martin-Iverson MT
Psychopharmacology (Berl); 2013 Jan; 225(2):483-94. PubMed ID: 22903389
[TBL] [Abstract][Full Text] [Related]
35. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
36. Chronic and acute adenosine A
Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
[TBL] [Abstract][Full Text] [Related]
37. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
Genn RF; Tucci S; Parikh S; File SE
Psychopharmacology (Berl); 2004 Dec; 177(1-2):93-9. PubMed ID: 15205871
[TBL] [Abstract][Full Text] [Related]
38. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
[TBL] [Abstract][Full Text] [Related]
39. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
Braida D; Sala M
Neuroreport; 2000 Jun; 11(9):2025-9. PubMed ID: 10884065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
